HK1112254A1 - Method of producing protein by using hamster igf-1 - Google Patents
Method of producing protein by using hamster igf-1Info
- Publication number
- HK1112254A1 HK1112254A1 HK08107585.8A HK08107585A HK1112254A1 HK 1112254 A1 HK1112254 A1 HK 1112254A1 HK 08107585 A HK08107585 A HK 08107585A HK 1112254 A1 HK1112254 A1 HK 1112254A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- producing protein
- hamster igf
- igf
- hamster
- protein
- Prior art date
Links
- 241000699800 Cricetinae Species 0.000 title 1
- 101150088952 IGF1 gene Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005044625 | 2005-02-21 | ||
JP2005275485 | 2005-09-22 | ||
PCT/JP2006/303045 WO2006088198A1 (ja) | 2005-02-21 | 2006-02-21 | ハムスターigf-1を用いたタンパク質の製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1112254A1 true HK1112254A1 (en) | 2008-08-29 |
Family
ID=36916594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08107585.8A HK1112254A1 (en) | 2005-02-21 | 2008-07-10 | Method of producing protein by using hamster igf-1 |
Country Status (11)
Country | Link |
---|---|
US (1) | US8062863B2 (xx) |
EP (2) | EP2172480B1 (xx) |
JP (1) | JP4999677B2 (xx) |
KR (1) | KR101273001B1 (xx) |
CN (1) | CN101151276B (xx) |
AU (1) | AU2006215012B8 (xx) |
CA (1) | CA2598570C (xx) |
HK (1) | HK1112254A1 (xx) |
SG (1) | SG174827A1 (xx) |
TW (1) | TWI406870B (xx) |
WO (1) | WO2006088198A1 (xx) |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0346429B1 (en) * | 1987-12-24 | 1994-12-28 | Gropep Pty. Ltd. | Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2) |
ATE300615T1 (de) | 1990-08-29 | 2005-08-15 | Genpharm Int | Transgene mäuse fähig zur produktion heterologer antikörper |
WO1993002227A1 (en) | 1991-07-15 | 1993-02-04 | Eco-Tec Limited | Process and apparatus for treating fluoride containing acid solutions |
AU675661B2 (en) | 1992-07-24 | 1997-02-13 | Abgenix, Inc. | Generation of xenogeneic antibodies |
US5285485A (en) | 1993-02-01 | 1994-02-08 | General Electric Company | Composite nuclear fuel container and method for producing same |
AU6819494A (en) | 1993-04-26 | 1994-11-21 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
JP3630453B2 (ja) | 1994-09-30 | 2005-03-16 | 中外製薬株式会社 | Il−6レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤 |
EP0822830B1 (en) | 1995-04-27 | 2008-04-02 | Amgen Fremont Inc. | Human anti-IL-8 antibodies, derived from immunized xenomice |
CA2219486A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
AUPN442295A0 (en) * | 1995-07-26 | 1995-08-17 | Commonwealth Scientific And Industrial Research Organisation | Regulated autocrine growth of mammalian cells |
WO2000040613A1 (en) | 1999-01-06 | 2000-07-13 | Genentech, Inc. | Insulin-like growth factor (igf) i mutant variants |
ES2329220T3 (es) * | 1999-01-06 | 2009-11-24 | Genentech, Inc. | Variantes mutantes del factor de crecimiento similar a insulina (igf) i. |
US7469185B2 (en) * | 2002-02-04 | 2008-12-23 | Ocimum Biosolutions, Inc. | Primary rat hepatocyte toxicity modeling |
CA2565987A1 (en) * | 2004-05-11 | 2005-11-24 | Wyeth | Oligonucleotide arrays to monitor gene expression and methods for making and using same |
-
2006
- 2006-02-20 TW TW095105658A patent/TWI406870B/zh not_active IP Right Cessation
- 2006-02-21 JP JP2007503780A patent/JP4999677B2/ja not_active Expired - Fee Related
- 2006-02-21 EP EP09176322.7A patent/EP2172480B1/en not_active Not-in-force
- 2006-02-21 EP EP06714185A patent/EP1857465A4/en not_active Withdrawn
- 2006-02-21 US US11/884,538 patent/US8062863B2/en not_active Expired - Fee Related
- 2006-02-21 KR KR1020077020531A patent/KR101273001B1/ko active IP Right Grant
- 2006-02-21 SG SG2011067550A patent/SG174827A1/en unknown
- 2006-02-21 AU AU2006215012A patent/AU2006215012B8/en not_active Ceased
- 2006-02-21 WO PCT/JP2006/303045 patent/WO2006088198A1/ja active Application Filing
- 2006-02-21 CN CN2006800102988A patent/CN101151276B/zh not_active Expired - Fee Related
- 2006-02-21 CA CA2598570A patent/CA2598570C/en not_active Expired - Fee Related
-
2008
- 2008-07-10 HK HK08107585.8A patent/HK1112254A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20070115945A (ko) | 2007-12-06 |
TW200640946A (en) | 2006-12-01 |
CN101151276A (zh) | 2008-03-26 |
AU2006215012B8 (en) | 2012-04-12 |
SG174827A1 (en) | 2011-10-28 |
WO2006088198A1 (ja) | 2006-08-24 |
KR101273001B1 (ko) | 2013-06-10 |
US8062863B2 (en) | 2011-11-22 |
EP2172480A2 (en) | 2010-04-07 |
EP2172480B1 (en) | 2013-08-14 |
CA2598570C (en) | 2016-03-22 |
US20090011453A1 (en) | 2009-01-08 |
JP4999677B2 (ja) | 2012-08-15 |
JPWO2006088198A1 (ja) | 2008-07-03 |
AU2006215012A1 (en) | 2006-08-24 |
EP2172480A3 (en) | 2010-09-08 |
CN101151276B (zh) | 2012-10-10 |
CA2598570A1 (en) | 2006-08-24 |
EP1857465A1 (en) | 2007-11-21 |
AU2006215012B2 (en) | 2012-02-09 |
TWI406870B (zh) | 2013-09-01 |
EP1857465A4 (en) | 2009-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1901820A4 (en) | PROCESS FOR REDUCING THE CONDITION OF PROTEINS RELATED TO DISEASES | |
EP1748077A4 (en) | PROCESS FOR PROTEIN PRODUCTION | |
IL190550A0 (en) | Methods of protein production using anti-senescence compounds | |
EP2035572A4 (en) | PROCESS FOR THE PREPARATION OF FACTOR VIII PROTEINS BY RECOMBINATION PROCEDURES | |
EP1854776A4 (en) | PROCESS FOR THE PRODUCTION OF OLEFINES | |
PL1713760T3 (pl) | Sposób wytwarzania dinitryli | |
IL180247A0 (en) | Method for producing 4- | |
ZA200805297B (en) | Method of using ß-hydroxy-ß-methylbutyrate | |
HK1143608A1 (en) | Method of producing heterogeneous protein | |
PL1969127T5 (pl) | Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji | |
EP1995254A4 (en) | PROCESS FOR PRODUCING PEPTIDE | |
IL177233A0 (en) | Method for producing polyisobutenylphenols | |
EP1932906A4 (en) | PROCESS FOR PRODUCING UF BY NUCLEAR TRANSPLANTATION | |
PL1835816T3 (pl) | Sposób wytwarzania hydrolizatów białkowych | |
EP2062974A4 (en) | PROCESS FOR PREPARING FUSION PROTEIN | |
PL1831223T3 (pl) | Sposób wytwarzania L-biopteryny | |
EP1748071A4 (en) | PROCESS FOR PRODUCTION OF POLYPEPTIDE | |
EP1790633A4 (en) | PROCESS FOR THE PREPARATION OF 2-HYDROXY-4-METHYLTHIOBUTAN ACID | |
PL1865784T3 (pl) | Sposób wytwarzania pojedynczych porcji | |
EP1860069A4 (en) | PROCESS FOR PREPARING A COMPOSITION | |
EP1878737A4 (en) | METHOD OF SYNTHESIZING INDAZOLE-3-YLMETHYLPHOSPHONIUM SALT | |
EP1914313A4 (en) | PROCESS FOR THE PRODUCTION OF CERCOSPORAMIDE | |
ZA200709013B (en) | Method for producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-butenoate | |
EP1927590A4 (en) | PROCESS FOR PREPARING A 1-SUBSTITUTED 5-ACYLIMIDAZOLE COMPOUND | |
EP1882743A4 (en) | PROCESS FOR PRODUCING A PROTEIN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200227 |